Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2017 | Evolution, not revolution: the acceptance of biosimilars by practicing clinicians

Mark Pegram • 22 Sep 2017
ESMO 2017
Breast Cancer

Mark Pegram, MD, from the Stanford Women’s Cancer Center, Stanford, CA discusses the topic of how practicing clinicians in oncology will accept the introduction of biosimilars into the clinic, talking us through the data they will soon be able to review and how this may affect their judgment. Similar situations have arisen in the past, and Dr Pegram gives us some examples of how clinicians reacted to new agents. This interview was recorded at the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain.

More from Mark Pegram

Biosimilars and the exciting results of the REFLECTIONS trial
4:38
Biosimilars and the exciting results of the REFLECTIONS trial
Mark Pegram • 22 Sep 2017

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals